Table 1 Sample Description.
ASD | CON | MHC | p value | |
|---|---|---|---|---|
n | 52 | 55 | 43 | NA |
gender (f/m) | 10/42 | 30/25 | 29/14 | < 0.001 |
age | 15.2 (2) | 14.9 (1.8) | 15.7 (1.9) | 0.112 |
verbal IQ | 97.3 (15.3) | 105.8 (11.5) | 101 (10.8) | < 0.001 |
non-verbal IQ | 101.5 (14.8) | 108 (11.2) | 102.7 (11.8) | < 0.001 |
CBCL | 65.9 (8.7) | 50.5 (10.1) | 61.5 (12.4) | < 0.001 |
YSR | 63 (8.9) | 55 (8.1) | 65.7 (12) | < 0.001 |
SRS | 24.9 (7.3) | 5.6 (6.4) | 11.7 (9.4) | < 0.001 |
SCQ | 15.2 (4.7) | 6.9 (4.2) | 9 (5.5) | 0.036 |
SP2 (auditory) | 16.9 (8.4) | 5.7 (5.7) | 11.4 (10.1) | 0.003 |
grip strength [z] | −1.8 (1.3) | −1.5 (1.4) | −1.1 (1.2) | 0.022 |
included ET trials [%] | 87 (12.1) | 85.7 (18.3) | 83.1 (19.6) | 0.54 |
included EEG trials [%] | 81.2 (24.2) | 91.4 (14.8) | 76.7 (35) | 0.013 |
trial duration [s] | 2.3 (0.4) | 2.2 (0.4) | 2.3 (0.6) | 0.803 |